Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2024-03-07
2024-09-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutraceutical Composition Containing Natural Products Derivatives on the Modulation of the Endocrine Neuroimmune Axis
NCT04810572
Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels
NCT00803699
Effects of Freeze Dried Strawberry Powder Supplementation on Vascular Function and Blood Markers of Cardiovascular Risk
NCT02557334
Effect of a Dietary Supplement on Lipid Pattern, Indexes of NAFLD and Systemic Inflammation in Healthy Subjects With Suboptimal LDL-C Levels
NCT06403748
Investigating the Sensory Attributes of Selenium-fortified Biscuits and Their Effects on Selenium-status
NCT03770676
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
3\. Study Goals and Objectives
The primary objective is to evaluate the impact of consuming selenium-biofortified strawberries for 30 days on serum selenium concentration in healthy adults. The secondary objective is to assess the influence of this intervention on glucose profile and hepatic function. • Fifty-five healthy adult volunteers (both sexes) will be randomly assigned to three groups:
* Control group: Consuming 100 grams of control strawberries daily.
* Intervention group (selenium-biofortified strawberries): Consuming 100 grams of selenium-biofortified strawberries daily.
* Intervention group (selenium supplement): Consuming a selenium supplement of 100 micrograms daily.
* The intervention period will be 30 days.
* Blood samples (serum and plasma) will be collected at baseline (T0) and at the end of the intervention (T30).
* Body weight, barefoot standing height, body mass index, and body composition will be measured at baseline and T30.
* Blood samples will be analyzed for:
* Selenium.
* Glucose
* Insulin
* insulin resistance
* insulin sensitivity
* β-cell function
* aminotransferase (AST)
* alanine aminotransferase (ALT)
* gamma-glutamyl transferase (GGT)
* albumin (ALB)
* Data will be recorded in a coded database to ensure participant privacy.
* Samples will be transported in certified containers for biological samples, and processed at the Molecular Biology section of the University of Palermo.
The statistical analyses will be carried out using specific software. To compare the baseline characteristics of the groups student t tests will be used. The comparison between the different groups of participants and within the same group between baseline and T30 will be carried out using One-Way ANOVA followed by Sidak test. Values will be expressed as mean ± standard deviation (mean ± SD). P-value ≤ 0.05 will be considered to be statistically significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
The control group received strawberries (control strawberries 100grams/day) that was without biofortification with the same characteristic of strawberries lettuce(soil, water, harvesting time) for 30 days
supplementation with control strawberry
control strawberry supplementation (100 grams/day) for 30 days
Selenium-biofortified strawberry supplementation
This group will received selenium biofortified strawberries (100grams/day) with the same characteristic of control strawberries lettuce(soil, water, harvesting time) for 30 days
supplementation with biofortified strawberry
selenium biofortified strawberry supplementation (100 grams/day) for 30 days
Tablet Selenium supplementation
This group will received selenium in tablet (100 micrograms/day) for 30 days
supplementation with selenium in tablet
selenium supplementation in tablet (100 micrograms/day) for 30 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
supplementation with control strawberry
control strawberry supplementation (100 grams/day) for 30 days
supplementation with biofortified strawberry
selenium biofortified strawberry supplementation (100 grams/day) for 30 days
supplementation with selenium in tablet
selenium supplementation in tablet (100 micrograms/day) for 30 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Italian Ethnicity
* Body mass index between 18.5 and 28.5 kg/m²
* Clinically Healthy
Exclusion Criteria
* Use of drugs (excluding occasional over the counter medications)
* Pregnancy
* Exogenous hormone use
* Breastfeeding
* Use of supplements
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Palermo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sara Baldassano
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sara Baldassano
Role: PRINCIPAL_INVESTIGATOR
NABbio, STEBICEF department Palermo, Italy, 90128
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, Palermo University
Palermo, PA, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SeStraw30Days24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.